Arcturus Therapeutics Holdings (ARCT) Leases (2019 - 2025)
Historic Leases for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to $23.8 million.
- Arcturus Therapeutics Holdings' Leases fell 1362.06% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year decrease of 1362.06%. This contributed to the annual value of $26.7 million for FY2024, which is 640.7% down from last year.
- Arcturus Therapeutics Holdings' Leases amounted to $23.8 million in Q3 2025, which was down 1362.06% from $24.8 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year Leases high stood at $34.5 million for Q2 2022, and its period low was $5.2 million during Q1 2022.
- Its 5-year average for Leases is $23.0 million, with a median of $27.6 million in 2024.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Leases crashed by 2159.94% in 2022, and later surged by 50165.87% in 2023.
- Arcturus Therapeutics Holdings' Leases (Quarter) stood at $5.6 million in 2021, then soared by 479.3% to $32.5 million in 2022, then dropped by 12.43% to $28.5 million in 2023, then fell by 6.41% to $26.7 million in 2024, then dropped by 10.63% to $23.8 million in 2025.
- Its Leases stands at $23.8 million for Q3 2025, versus $24.8 million for Q2 2025 and $25.7 million for Q1 2025.